Reika Miyokawa
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Reika Miyokawa’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$57,942
Medicare paid this office $57,942 for 206 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 84 | $45,147 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,428 | $106 |
| Return visit (30+ min) | 26 | $2,191 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,005 | $134 |
| New patient visit (45+ min) | 19 | $1,803 | $95 |
See all 10 services
| Critical care, first 30-74 minutes | 84 | $45,147 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $2,428 | $106 |
| Return visit (30+ min) | 26 | $2,191 | $76 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,005 | $134 |
| New patient visit (45+ min) | 19 | $1,803 | $95 |
| Short return visit (20+ min) | 31 | $1,624 | $51 |
| Test to determine lung volumes using sensors | 21 | $211 | $10 |
| Test to examine how well the lungs exchange gases | 24 | $180 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $136 | $9 |
| Test to measure expiratory airflow and volume | 12 | $81 | $7 |
Who their Medicare patients are
206 Original Medicare patients in 2024. Average age 72 · Under 65 15% · 85 and older 16% · Women 52% · Also on Medicaid 82% · Health risk score 2.91. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 48% · Heart failure 47% · COPD 43% · Chronic kidney disease 40% · Coronary heart disease 34% · Atrial fibrillation 30% · Depression 25% · Dementia 24% · Cancer 23% · Stroke 19%.
The office billed $647,210, Medicare allowed $75,764 and paid $57,942; for 470 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 206 | 470 | 72 | 2.91 | $647,210 | $57,942 |
| 2023 | 71 | 138 | 70 | 2.91 | $190,339 | $18,666 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Critical care, first 30-74 minutes | 28 | $14,284 | $188 |
| Short return visit (20+ min) | 19 | $1,133 | $60 |
Medicaid work
$10,409 in 2024
Medicaid paid $10,409 for 758 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 341 | $10,224 |
| Return visit (30+ min) | 12 | $45 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 69 | $43 |
| Short return visit (20+ min) | 15 | $30 |
| Diffusing capacity | 73 | $30 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 36 | $25 |
| EVALUATION OF WHEEZING | 26 | $13 |
| Medication list documented in medical record (COA) | 114 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 12 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 60 | $0 |
| 2024 | 758 | 10 | 30 | $10,409 |
| 2023 | 79 | 1 | 15 | $1,748 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 79 | $1,748 |
Drugs they prescribed that Part D paid
$177,460
Pharmacies billed $177,460 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 431) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
169 generic and 262 brand-name prescriptions · $177,460 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 16 | $56,072 | $3,505 |
| Spiriva Handihaler | 19 | $12,981 | $683 |
| Breo Ellipta | 29 | $10,023 | $346 |
| Incruse Ellipta | 20 | $6,993 | $350 |
| Anoro Ellipta | 12 | $5,438 | $453 |
See all 14 drugs
| Dupixent | 16 | $56,072 | $3,505 |
| Spiriva Handihaler | 19 | $12,981 | $683 |
| Breo Ellipta | 29 | $10,023 | $346 |
| Incruse Ellipta | 20 | $6,993 | $350 |
| Anoro Ellipta | 12 | $5,438 | $453 |
| Fluticasone-Salmeterol | 43 | $5,226 | $122 |
| Wixela Inhub | 37 | $4,540 | $123 |
| Qvar Redihaler | 11 | $3,008 | $273 |
| Arnuity Ellipta | 12 | $2,390 | $199 |
| Sildenafil Citrate | 12 | $1,591 | $133 |
| Albuterol Sulfate Hfa | 26 | $1,003 | $39 |
| Bumetanide | 12 | $205 | $17 |
| Fluticasone Propionate | 18 | $186 | $10 |
| Montelukast | 28 | $144 | $5 |
Year by year
| 2024 | 431 | 74 | 0% (0) | 61% | $177,460 |
| 2023 | 101 | 42 | 0% (0) | 67% | $41,580 |
| 2022 | 59 | 18 | 0% (0) | 54% | $17,341 |
| 2021 | 112 | 23 | 0% (0) | 34% | $24,060 |
| 2020 | 452 | 65 | 9% (40) | 28% | $108,233 |
| 2019 | 587 | 114 | 11% (64) | 24% | $74,718 |
| 2018 | 40 | 19 | 0% (0) | None | $3,310 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Advair Diskus | 12 | $8,040 | $670 |
2022: 1 drug
| Albuterol Sulfate Hfa | 16 | $1,078 | $67 |
2021: 2 drugs
| Incruse Ellipta | 14 | $7,483 | $534 |
| Albuterol Sulfate Hfa | 27 | $1,475 | $55 |
2020: 8 drugs
| Symbicort | 11 | $5,123 | $466 |
| Ventolin Hfa | 20 | $1,171 | $59 |
| Hydrocodone-Acetaminophen | 19 | $445 | $23 |
| Diclofenac | 18 | $411 | $23 |
| Gabapentin | 37 | $314 | $8 |
| Hydroxyzine | 16 | $274 | $17 |
| Atorvastatin | 20 | $246 | $12 |
| Cyclobenzaprine | 11 | $70 | $6 |
2019: 11 drugs
| Morphine Sulfate | 13 | $1,534 | $118 |
| Ventolin Hfa | 17 | $1,093 | $64 |
| Morphine Sulfate Er | 13 | $1,017 | $78 |
| Hydroxyzine | 16 | $472 | $29 |
| Atorvastatin | 15 | $333 | $22 |
| Gabapentin | 15 | $303 | $20 |
| Hydrocodone-Acetaminophen | 23 | $273 | $12 |
| Trazodone | 14 | $165 | $12 |
| Lisinopril | 13 | $142 | $11 |
| Clopidogrel | 11 | $106 | $10 |
| Amlodipine Besylate | 11 | $40 | $4 |
Money from drug and device companies
$22 in 2025
| 2025 | 1 | 1 | None | $22 |
| 2024 | 1 | 1 | None | $23 |
| 2019 | 1 | 1 | None | $90 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Actelion Pharmaceuticals US | Uptravi | $22 | 1 payment
|
See the published payment
| Actelion Pharmaceuticals US | Meals · 2025-05-07 | Uptravi | $22 |
See earlier years (2024, 2019)
2024: $23
| Actelion Pharmaceuticals US | Uptravi | $23 | 1 payment
|
2019: $90
| GlaxoSmithKline | Benlysta | $90 | 1 payment
|
Professional record
- NPI
- 1619408333
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- 4150 V St # 1100, Sacramento, CA, 95817
- NPI first listed
- 2017-03-24
- NPI last updated
- 2026-07-09
- NPI record certified
- 2026-07-09
This is when the NPI record was last certified, not a medical board exam.